The Orthopaedic Implant Company08.14.19
The Orthopaedic Implant Company (“OIC”), a leading high-value orthopedic implant manufacturer, has released its Trochanteric Antegrade Femur Intramedullary Nail (“TAFN”).
The TAFN is part of the OIC Intramedullary Nail System, designed to support surgeons and facilities in successfully moving from fee-for-service to value-based care. The TAFN is indicated for simple and comminuted fractures occurring in and between the proximal third and distal fourth of the femur. It is available in diameters ranging from ten to thirteen millimeters and 320 to 440 millimeters in length.
“Our focus in design is simplicity and consistency. Because it utilizes instrumentation surgeons already use, it’s instantly familiar and an obvious device to select for the appropriate indications,” said Todd Martens, VP of design and customer experience.
In addition to the TAFN, the OIC IM Nail System includes hip nails, a piriformis-entry antegrade and retrograde femur nail, as well as a tibial nail indicated for infra- and suprapatellar approaches.
The TAFN is part of the OIC Intramedullary Nail System, designed to support surgeons and facilities in successfully moving from fee-for-service to value-based care. The TAFN is indicated for simple and comminuted fractures occurring in and between the proximal third and distal fourth of the femur. It is available in diameters ranging from ten to thirteen millimeters and 320 to 440 millimeters in length.
“Our focus in design is simplicity and consistency. Because it utilizes instrumentation surgeons already use, it’s instantly familiar and an obvious device to select for the appropriate indications,” said Todd Martens, VP of design and customer experience.
In addition to the TAFN, the OIC IM Nail System includes hip nails, a piriformis-entry antegrade and retrograde femur nail, as well as a tibial nail indicated for infra- and suprapatellar approaches.